Advertisement

Topics

Latest "Centre Partners" News Stories - Page: 20

22:12 EDT 15th August 2018 | BioPortfolio

Here are the most relevant search results for "Centre Partners" found in our extensive news archives from over 250 global news sources.

More Information about Centre Partners on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Centre Partners for you to read. Along with our medical data and news we also list Centre Partners Clinical Trials, which are updated daily. BioPortfolio also has a large database of Centre Partners Companies for you to search.

Showing "Centre Partners" News Articles 476–500 of 5,900+

Probably Relevant

Animals, Fungi Enhance the Performance of Forests

NewsA new study shows that in addition to the diversity of tree species, the variety of animal and fungus species also has a decisive influence on the performance of forests.


Mom’s attitude to baby during pregnancy may impact child’s development

Mothers who ‘connect’ with their baby during pregnancy are more likely to interact in a

J&J partners with Boston University to tackle lung cancer

Johnson & Johnson Innovation has launched a five-year partnership with Boston University to develop new solutions for the prevention, interception...Read More... The post J&J partners with Boston University to tackle lung cancer appeared first on Pharmaceutical Technology.


Chris Nave, Brandon Capital Partners: Passionate about turning innovative science into improved medical outcomes

In this interview filmed at Ausbiotech in Brisbane, Fintan Walton talks to Chris Nave, Managing Director, Brandon Capital Partners. Brandon Capital Partners makes seed and venture capital investments to support the development and international growth of Australian life science companies. They work collaboratively with entrepreneurs to demonstrate the benefit of their technology, thereby creating ...

Enter now and take the next step in your career

The PharmaTimes Marketer of the Year Awards will return to London in November, alongside Communications Team of the Year and the all-new Sales Awards. Get involved with the 25th anniversary celebrations as this unique competition continues to raise standards, drive innovation and put patient outcomes at the centre of healthcare marketing.

£40m Innovation Hub planned for Newcastle

A £20m innovation hub for ageing science is to be established in Newcastle as part of a package of measures aimed at cementing the north as a world leader in science and technology, is has been confirmed. The National Centre for Ageing Science and Innovation (NASI) will "lead the UK’s efforts" to improve the health and well-being of older people by developing new technologies and ...

$340M life sciences crossover fund launched by Sofinnova Partners

The life sciences-focused Sofinnova Crossover Fund I was launched by Paris-based venture capital firm Sofinnova Partners afte -More- 

PTV News: Nov 24, 2009

Top stories on November 24th, 2009: Cephalon's Cinquil set-back Biogen CEO attacked over share sales and pay Merck Serono plans global R&D centre in China Norway's Clavis in US$ 380M development deal Action Shares Teva "jumps gun" with Novartis generic "Take your tablets!" -  

Precision medicine: The Christie Hospital as avanguard cancer centre

Prof Andrew Hughes presents at ecancer's Milan Summit on Precision Medicine 2018 about how precision medicine requires a multidisciplinary effort to maximise its potential. He touches upon circulating free DNA, genetic profiling, and also the ethics of...

Precision medicine: The Christie Hospital as a vanguard cancer centre

Prof Andrew Hughes presents at ecancer's Milan Summit on Precision Medicine 2018 about how precision medicine requires a multidisciplinary effort to maximise its potential. He touches upon circulating free DNA, genetic profiling, and also the ethics of...

New insight into how Autism might develop in human brain

(McGill University) In a study published in Stem Cell Reports, a McGill University team of scientists led by Dr. Carl Ernst, researcher at the Douglas Hospital Research Centre, revealed a molecular mechanism that may play a role in the development of autism.

Advanced Therapies Manufacturing Taskforce

Cobra’s objective in the UK is to become a centre of excellence for the manufacturing of AMTs from pre-clinical to commercial supply. They already have a global reputation GMP manufacturing in this area and are looking forward to further expansion to commercial supply in this exciting and innovative sector.As you may be aware, Cobra Biologics has been intrinsically linked to Cell and Gene Th...

Enterprise Europe Network – Partnership Opportunities

The Enterprise Europe Network is a business support network that provides clients with free of charge support to innovate and internationalise. The Network provides advice on doing business internationally, helps provide access to EU funding and finance and helps clients find collaborative partners. The Network receives requests from across Europe and beyond from various entities looking to build...

CCNY and international partners explore sustainable reuse of wind turbine blades

(City College of New York) With the rapid development of wind energy technology in the past 15 years comes a new conundrum: how to dispose of the non-biodegradable blades in current wind turbines in a sustainable way. The City College of New York and its international partners are on it.

How to diagnose overdiagnosis

Overdiagnosis means different things to different people. Stacy Carter, associate professor at the Centre for Values, Ethics and the Law in Medicine at the University of Sydney argues that we should use a broad term such as too much medicine for advocacy and develop precise, case by case definitions of overdiagnosis for research and clinical...

Cota Lands $40M to Accelerate Value-based Precision Medicine

Cota, a NYC-based healthcare data and analytics company bridging precision medicine to population health has raised $40 million in Series C funding led by QVIA and was contributed to by EW Healthcare Partners. Memorial Sloan Kettering Cancer Center also participated in the round, along with existing Cota investors which include, Boston Millennia Partners, Horizon Blue Cross ... Read More

VFS Global Awarded Contracts to Provide Canadian Visa Application Centre Services in 78 Countries

     (Logo: http://mma.prnewswire.com/media/624234/VFS_Global_Logo.jpg) VFS Global has been serving the Canadian Government since 2005 and currently operates Visa Application Centres (VACs) in five continents for Read more...

Bristol-Myers Squibb Co (BMY) Stake Decreased by Private Wealth Partners LLC

Private Wealth Partners LLC lessened its position in shares of Bristol-Myers Squibb Co by 14.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,820 shares of the biopharmaceutical company's stock after selling 1,000 shares during the period.

GBS Venture Partners: Investing in Australia

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Geoff Brooke, Co-Founder and Managing Partner of GBS Venture Partners. Filmed at AusBiotech 2009, they discuss: • the way the life sciences industry has developed within Australia over the last 10 years • investment opportunities within the country • how Australian biotech companies were affected by the global fin...

Battle Lines Drawn as EU Court Weighs Fate of Gene-Edited Crops

Gene editing in agriculture takes centre stage next Wednesday when Europe's highest court rules in a case that could determine the fate of the technology that is already making waves in the field of medicine. Reuters Health Information

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for the treatment of a variety of seizure disorders.

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Kite will support Gadeta in the development of a new type of CAR-T therapy that could be more effective in solid tumors. Approved just last year, CAR-T cell therapy is offering hope to patients with severe forms of blood cancer. ... The post Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy appeared first on Labiotech.eu.

Another build for WuXi Biologics with $240m investment in Northern China

CDMO WuXi Biologics has announced plans to build a biologics centre in China, where it will develop and manufacture large molecule drugs for clinical and commercial production.

Baby with brain damage dies after parents run out of legal options

A profoundly brain damaged baby at the centre of a legal battle over the withdrawal of life support has died after his parents exhausted all possible legal avenues in a bid to keep him alive.Doctors...

Arthritis drugs potentially safe for expectant mothers

(McGill University Health Centre) A new study led by a team at the Research Institute of the MUHC (RI-MUHC) in Montreal has revealed that pregnant women with rheumatoid arthritis (RA) may be able to use certain RA drugs without possible increased health risks to their unborn babies.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks